Hisun Pharmaceutical: Subsidiary obtains veterinary drug product approval number certificate

Hisun Pharmaceutical announced that its controlling subsidiary, Zhejiang Hisun Animal Health Products Co., Ltd., received approval from the Ministry of Agriculture and Rural Affairs for a veterinary drug product registration certificate for a compound fipronil praziquantel moxidectin spot-on solution. The approval number is valid from September 10, 2026 to September 9, 2031. The product is used to prevent and treat internal and external parasite infections in cats. This approval will enrich the company's product portfolio and advance its strategic layout in the pet medicine sector. There is uncertainty regarding the product's launch and sales, and investors are advised to be aware of investment risks.